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Cross Talk between the Cell Wall Integrity and Cyclic AMP/Protein
Kinase A Pathways in Cryptococcus neoformans
Maureen J. Donlin,a,b Rajendra Upadhya,c Kimberly J. Gerik,c Woei Lam,c Laura G. VanArendonk,d Charles A. Specht,e
Neil K. Sharma,c Jennifer K. Lodgec
Edward A. Doisy Department of Biochemistry and Molecular Biologya and Department of Molecular Microbiology and Immunology,b Saint Louis University School of
Medicine, St. Louis, Missouri, USA; Department of Molecular Microbiologyc and Center for Genome Sciences and Systems Biology,d Washington University School of
Medicine, St. Louis, Missouri, USA; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USAe
ABSTRACT Cryptococcus neoformans is a fungal pathogen of immunocompromised people that causes fatal meningitis. The fun-
gal cell wall is essential to viability and pathogenesis of C. neoformans, and biosynthesis and repair of the wall is primarily con-
trolled by the cell wall integrity (CWI) signaling pathway. Previous work has shown that deletion of genes encoding the four ma-
jor kinases in the CWI signaling pathway, namely, PKC1, BCK1,MKK2, andMPK1 results in severe cell wall phenotypes,
sensitivity to a variety of cell wall stressors, and for Mpk1, reduced virulence in a mouse model. Here, we examined the global
transcriptional responses to gene deletions of BCK1,MKK2, andMPK1 compared to wild-type cells. We found that over 1,000
genes were differentially expressed in one or more of the deletion strains, with 115 genes differentially expressed in all three
strains, many of which have been identified as genes regulated by the cyclic AMP (cAMP)/protein kinase A (PKA) pathway. Bio-
chemical measurements of cAMP levels in the kinase deletion strains revealed significantly less cAMP in all of the deletion
strains compared to the wild-type strain. The deletion strains also produced significantly smaller capsules than the wild-type
KN99 strain did under capsule-inducing conditions, although the levels of capsule they shed were similar to those shed by the
wild type. Finally, addition of exogenous cAMP led to reduced sensitivity to cell wall stress and restored surface capsule to levels
near those of wild type. Thus, we have direct evidence of cross talk between the CWI and cAMP/PKA pathways that may have
important implications for regulation of cell wall and capsule homeostasis.
IMPORTANCE Cryptococcus neoformans is a fungal pathogen of immunocompromised people that causes fatal meningitis. The
fungal cell wall is essential to viability and pathogenesis of C. neoformans, and biosynthesis and repair of the wall are primarily
controlled by the cell wall integrity (CWI) signaling pathway. In this study, we demonstrate that deletion of any of three core
kinases in the CWI pathway impacts not only the cell wall but also the amount of surface capsule. Deletion of any of the kinases
results in significantly reduced cellular cyclic AMP (cAMP) levels, and addition of exogenous cAMP rescues the capsule defect
and some cell wall defects, supporting a direct role for the CWI pathway in regulation of capsule in conjunction with the cAMP/
protein kinase A pathway.
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Cryptococcus neoformans is a fungal pathogen of immunocom-promised people that causes an estimated 1 million infections
each year among HIV-positive patients globally, resulting in
600,000 deaths annually (1). Much of the disease burden occurs in
sub-Saharan Africa, where deaths from cryptococcal infections
may exceed those from tuberculosis in some areas (1). Cryptococ-
cal infections can be successfully treated with antifungal agents,
but the mortality rate remains 15 to 30%, even in the context of
antiviral treatments for HIV (2–4). The closely related species
Cryptococcus gattii can infect immunocompetent people and ani-
mals. Although C. gattii is more common in Australia, it received
global attention in 1999 when it emerged on Vancouver Island in
Canada and has since spread into other areas of the Pacific North-
west (5–7).
Infection byC. neoformans occurs upon inhalation of spores or
desiccated yeast cells, which can then disseminate to the brain and
cause fatal meningitis (reviewed in references 8, 9, and 10).C. neo-
formans rapidly establishes an infection in lung alveoli, where low
iron availability and increased carbon dioxide levels induce the
formation of a polysaccharide capsule on the surface of the cryp-
tococcal cell. The C. neoformans capsule has been shown to be
protective against phagocytosis and oxidative stress as well as re-
ducing the T-cell immune response (11, 12). The capsule is a key
virulence factor, and strains with disruptions or deletions of
capsule-related genes are usually avirulent or demonstrate atten-
uated virulence in murine models of infection (reviewed in refer-
ence 13).
C. neoformans is a soilborne pathogen found ubiquitously in
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the environment of temperate zones that can also infect and per-
sist in mammalian hosts. Thus, C. neoformans must be able to
grow under a wide range of pHs and temperatures and be able to
cope with a variety of exogenous stresses secreted by other soil
organisms or mammalian host cells. The ability to survive in such
diverse environments requires that the cell be able to sense and
process multiple signals from the environment that result in acti-
vation of various signaling cascades to allow adaption to and
growth under different conditions (reviewed in reference 14).
The cryptococcal cell wall is vital for maintaining cell morphol-
ogy and forms the scaffold for capsule attachment. Cell wall ho-
meostasis is maintained by the cell wall integrity (CWI) pathway,
which has 4 core kinases, protein kinase C (Pkc1), bypass of pro-
tein kinase C (Bck1), mitogen-activated kinase kinase (Mkk2),
and mitogen-activated protein kinase (Mpk1), all of which are
necessary for a fully functional cell wall. The primary kinase for
this pathway is Pkc1, a diacylglycerol-activated protein kinase C
essential for responding to a variety of cell wall stresses and whose
deletion results in severe cell wall defects, reduced melanin, and
disrupted capsule (15, 16). Strains with a deletion of the BCK1 or
MKK2 gene show increased sensitivity to cell wall stressors and
high temperature as well as delayed melanin formation (17). De-
letion of the gene encoding the putative terminal kinase in the cell
wall integrity pathway,MPK1, results in attenuated virulence (18)
and has been shown to reduce virulence when deleted in C. gattii
(19). Previous studies of the CWI pathway have used phosphory-
lation of the terminal kinase, Mpk1, as a marker for activation of
the pathway (18). We have demonstrated that in response to ni-
trosative or oxidative stress, PKC1 is required for phosphorylation
of the terminal kinase, Mpk1 (16). However, in a pkc1 strain,
Mpk1 is still phosphorylated in response to heat shock, but not
when the BCK1 or MKK2 gene is deleted (20), suggesting that
inputs into this signaling cascade can bypass some of the core
kinases and still result in activation of the pathway. We hypothe-
size that this pathway is likely to interact with other signaling
cascades, such as the HOG1 and cyclic AMP (cAMP)/protein ki-
nase A (PKA) pathways that respond to various exogenous
stresses. To address this hypothesis, we used RNA sequencing to
examine the genome-wide expression differences between the
wild type and deletions in three of the core CWI kinases, BCK1,
MKK2, and MPK1. We find strong evidence of cross talk between
the cAMP/PKA and CWI pathways based on the genes differen-
tially expressed in the kinase deletion strains. We demonstrate that
deletion of any of the three kinases results in significantly de-
creased cAMP levels and reduced surface capsule and that exoge-
nous cAMP can partially rescue the capsule- and cell wall-related
defects of the bck1, mkk2, and mpk1 strains.
RESULTS
Impact of CWI kinases on the transcriptome. The expression
profiles of the three kinase deletion strains (bck1, mkk2, and
mpk1 strains) were compared to wild-type C. neoformans KN99
MATa (KN99a) when grown at 30°C in yeast extract-peptone-
dextrose (YPD) medium plus 1 M sorbitol to an optical density
(OD) of 1.0. We initially included a deletion of the PKC1 gene in
the experiment, which necessitated the use of sorbitol to act as a
stabilizer (16). The RNA expression data revealed that the pkc1
strain was aneuploid, and thus, it was excluded from further anal-
yses. Overall, 1,064 genes showed statistically significant differen-
tial expression with a corrected P value cutoff of0.05 (Table 1;
see Table S2 in the supplemental material) (21). More genes were
differentially expressed in the bck1 strain (627 genes) than in the
mkk2 (511 genes) and mpk1 (453 genes) strains. Of the 1,064
differentially expressed genes, 653 genes were found in only one of
the three strains with a fairly even distribution: 244 genes were
unique to the bck1 strain, 203 were unique to the mkk2 strain,
and 206 were unique to the mpk1 strain (Fig. 1).
There were 116 transcripts differentially expressed in all three
of the deletion strains, including genes involved in carbohydrate
metabolism, cell wall biogenesis, transport, and signaling (see Ta-
ble S3 in the supplemental material). Of the 116 genes, 115 were in
concordance among the three mutant strains, with 71 upregulated
genes and 44 downregulated genes compared to the wild type. The
one gene that was not in concordance was a gene encoding a hy-
pothetical protein of unknown function. We identified 10 of the
TABLE 1 Number of differentially expressed genes
Strain(s)
No. of genes No. of unique genes
Total Upa Downa Total Up Down
bck1 strain 627 340 287 244 171 73
mkk2 strain 511 121 390 203 27 176
mpk1 strain 453 278 175 206 127 79
bck1 and mkk2 strains 164 39 123
bck1 and mpk1 strains 103 85 13
mkk2 and mpk1 strains 28 12 11
bck1, mkk2, and mpk1 strains 116 44 71
a For genes found in more than one strain, they were listed as upregulated (Up) or downregulated (Down) only if the direction of the expression difference was concordance.
FIG 1 Comparison of the distribution and overlap of the differentially ex-
pressed genes in the CWI kinase deletion strains, the bck1, mkk2, and
mpk1 strains.
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115 genes as related to cell wall or capsule homeostasis, reflecting
the importance of these kinases working in concert to maintain
cell wall integrity (CWI).
Differential expression of cell wall- and capsule-related
genes. Among all of the differentially expressed transcripts, we
identified 29 genes that are known or predicted to be involved in
cell wall biogenesis, cell wall regulation, or capsule synthesis (Ta-
ble 2). Six of the eight chitin synthase genes, CHS1, CHS4, CHS5,
CHS6, CHS7, and CHS8, show altered expression in two or more
of the kinase deletion strains (Table 2). The CHS1, CHS4, and
CHS5 genes show altered expression in all three deletion strains,
with CHS1 upregulated and CHS4 and CHS5 showing decreased
expression. A deacetylase gene, FPD1, for which no function has
yet been identified (22) was downregulated in all three deletion
strains, suggesting a possible adaptive response to the cell wall
stress induced by the deletions. The KRE6 gene, which is involved
in -1,6-glucan synthesis (23), was modestly upregulated in the
bck1 strain, but KRE61, a homolog of KRE6 with no known
function, was highly repressed in all three deletions, again suggest-
ing a possible adaptive response or regulation of this gene by the
CWI pathway. Of the nine capsule-related genes that are differen-
tially expressed, seven are changed in the bck1 strain, but only
one (CAP59) is found in all three deletion strains, precluding a
significant role for the CWI pathway in transcriptional regulation
of capsule biosynthesis. Although CAP59 has been associated
mostly with capsule defects, it may have a role in general secretion,
rather than a capsule-specific role (24).
Reduced chitin levels in the CWI kinase deletion strains. All
of the deletion strains had significant cell wall phenotypes, which
likely affect cellular chitin and chitosan levels. We determined the
chitin and chitosan content of the cell walls, and all three had
significantly more chitin and significantly less chitosan than did
the wild-type KN99a strain (Fig. 2). The chitin synthase gene,
CHS3, responsible for the majority of chitosan synthesis during
vegetative growth was unchanged in these deletion strains, as were
two of the three chitin deacetylase genes. Three chitin synthase
genes, CHS1, CHS4, and CHS5, had altered expression in all three
of these deletion strains (Table 2). Previous work on the CHS
genes revealed no phenotypes when CHS1 was deleted, although
CHS1 transcript could be detected in vegetatively growing cells
(25). Strains with deletion of either CHS4 or CHS5 have reduced
chitin and increased chitosan content, but otherwise had no other
in vitro cell wall phenotypes (25). These data suggest a possible
role for CHS1, CHS4, and/or CHS5 in maintaining cell wall mor-
phology but one that is dependent on the CWI kinases. Previous
work has demonstrated an important role for chitin oligomers in
TABLE 2 Cell wall- or capsule-related genes










CNAG_00261 MPN10 putative mannoprotein 0.43
CNAG_00546 CHS4 chitin synthase activity 1.22 1.33 1.01 25
CNAG_00914 KRE6 -glucan synthase 0.42 23
CNAG_01230 CDA2 chitin deacetylase 0.61 22
CNAG_01234 SPO71 similar to S. cerevisiae spore wall assembly protein 1.07 1.81
CNAG_01341 MPI1 putative mannose-6-phosphate isomerase 1.17
CNAG_02071 BNI4 scaffold protein 0.47 50
CNAG_02217 CHS7 chitin synthase 0.87 1.15 25
CNAG_02225 EXG1 cellulase 1.11 0.61 51
CNAG_03099 CHS1 chitin synthase 1.03 1.15 0.59 25
CNAG_03223 MPN6 putative mannoprotein 1.30 1.25 1.35
CNAG_03345 SSD1 translational repressor 0.63 17
CNAG_03465 LAC1 laccase melanin synthesis 0.75 1.18 0.66 52
CNAG_03782 MPN11 putative mannose protein 3.34
CNAG_05663 SCW1 similar to S. cerevisiae cell wall integrity protein 0.37 0.55
CNAG_05818 CHS5 chitin synthase 1.46 1.31 1.34 25
CNAG_06291 FPD1 polysaccharide deacetylase 0.68 1.19 0.66 22, 51
CNAG_06487 CHS6 chitin synthase 0.51 0.50 25
CNAG_06835 KRE61 -glucan synthase 1.33 2.79 1.03 23
CNAG_07499 CHS8 chitin synthase 0.56 25
Capsule-related genes
CNAG_00600 CAP60 capsule-associated protein 0.81 53
CNAG_00721 CAP59 capsule-associated protein 0.75 0.67 0.31 54
CNAG_01172 PBX1 parallel -helix repeat protein 0.35 55
CNAG_01371 CRG2 regulator of G-protein signaling 0.46 56, 57
CNAG_01654 CAS34 capsule structure protein 0.61 58
CNAG_02581 CAS33 capsule-associated protein 0.39 59
CNAG_03735 CAP4 glycosyltransferase 0.67 0.56 58
CNAG_05081 PDE1 phosphodiesterase 0.89 60
CNAG_07554 CAP10 glycosyltransferase 0.59 61
a Broad ID, Broad identification or locus tag.
b The log2 fold changes in the level of expression for the bck1, mkk2, and mpk1 deletion strains compared to that of the wild-type (WT) strain are shown.
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capsule attachment (26, 27). However, the source of the chitin for
the oligomers has not been determined. It is plausible that CHS1,
CHS4, and/or CHS5 may play a role in producing the chitin nec-
essary for capsule attachment.
Overlap of differentially expressed genes with other stress-
responsive signaling pathways. Because of the cell wall and stress
phenotypes associated with the CWI kinase deletion strains, we
compared our differentially expressed gene lists with those gener-
ated from deletions in genes that regulate the cAMP/PKA pathway
(28), the HOG1 stress pathway (29), and capsule synthesis (30–
32). There is a substantial overlap in genes identified as differen-
tially expressed in all of these studies, which is expected given that
these gene lists include several hundred to thousands of genes. We
narrowed the search to examine the overlap of genes differentially
expressed in all three of our deletion strains with these other data
sets (see Table S3 in the supplemental material). We found the
greatest overlap (54 and 56 genes, respectively) with genes depen-
dent on HOG1, a mitogen-activated protein (MAP)-type kinase
involved in osmoregulation (33) and SSK1, a response receiver
protein that modulates Hog1 activity (34). We found substantial
overlap (38 genes) withRIM101-dependent genes (31), with genes
dependent onNRG1 (31 genes) (32) and with genes dependent on
SKN7 (27 genes), another response receiver protein that regulates
sensitivity to Na ions (34). Out of the 115 genes differentially
expressed in all three CWI kinase deletion strains were 10 genes
that have a known or predicted role in cell wall or capsule biosyn-
thesis or regulation. Of the 10 genes, 6 genes overlap with the genes
of a skn7 strain, 5 overlap with those of a hog1 strain (29), and
5 overlap with those of a nrg1 strain (32) (Table S3). Although
these high-throughput experiments were conducted under differ-
ent conditions, the genes differentially expressed in various dele-
tion strains suggest a central role for these genes in response to
perturbation of the different signaling pathways and potential
mechanisms of cross talk between the pathways.
Reduced intracellular cAMP in CWI kinase deletion strains.
Recent work has demonstrated the importance of the RIM101
transcription factor in the cAMP/PKA-dependent regulation of
capsule production, defining a novel interaction between the Rim
and PKA signaling pathways in C. neoformans (30). PKA1 acti-
vates the transcription factor NRG1, leading to the transcriptional
activation of genes directly involved in capsule assembly (35). The
Hog1 kinase is known to be a negative regulator of capsule syn-
thesis in serotype A (33), a process that requires cAMP. In addi-
tion, the gene encoding Smg1, identified as a suppressor of Gpa1,
the G alpha subunit that functions in cAMP signaling (36), was
significantly repressed in all three CWI kinase deletion strains.
The overlap between genes differentially expressed in the kinase
deletion strains and those differentially expressed in gene deletion
strains related to the PKA/cAMP pathway led us to ask if loss of the
CWI kinases might negatively impact cellular cAMP levels. We
measured cAMP levels in the three deletion strains and wild-type
KN99a during log-phase growth in YPD medium. These experi-
ments were done on two separate days, with three replicates for
each strain. Since we observed the differential gene expression
under log growth in nutrient-rich conditions and not in response
to stress, we wanted to measure the cAMP levels under similar
conditions. The kinase deletion strains, bck1, mkk2, and
mpk1 strains, all showed significantly less cAMP compared to
the KN99a wild-type strain (Fig. 3A). The experiments do not
address the effect of cAMP in response to stress; however, the
significant decrease in cAMP levels among all three deletion
strains provides strong evidence for an impact on basal cAMP
activity.
We tested whether the addition of exogenous cAMP could mit-
igate the sensitivity of the deletions to SDS, calcofluor white, and
Congo red. Exogenous cAMP almost completely rescues the sen-
sitivity to SDS for bck1, mkk2, and mpk1 strains after 5 days
(Fig. 3B), but it has a lower effect on sensitivity to calcofluor white
and does not rescue sensitivity to Congo red (data not shown). It
is possible that the different stresses activate the CWI and cAMP/
PKA pathways by different mechanisms, with various degrees of
overlap between the activating mechanisms. An alternative expla-
nation may be that cell membranes are more permeable in the
presence of SDS. cAMP does not readily cross cell membranes,
and the fact that we saw an effect with SDS but not with Congo red
may reflect increased permeability in the presence of SDS, which
does not happen with Congo red treatment.
Capsule defect in the CWI kinase deletion strains. To further
investigate the cross talk between the cAMP/PKA and CWI path-
ways, we examined phenotypes associated with disrupted cAMP
levels, specifically, capsule formation when grown in capsule-
inducing low-iron medium (LIM) (37). When the deletion strains
were grown in LIM, all three had visibly reduced capsule com-
FIG 2 C. neoformans BCK1, MKK2, and MPK1 are required for full chitin
production. Chitin and chitosan levels of C. neoformans KN99a, KN99, and
bck1, mkk2, and mpk1 deletion strains. Measurements of strains were
taken after 70 h of growth in liquid YPD at 25°C and reported as average
nanomoles per milligram (dry weight) of chitin and chitosan as indicated.
Each measurement represents the average from three independent cultures for
each strain, and error bars indicate standard deviations. The levels of chitin
and chitosan for the bck1, mkk2, and mpk1strains were compared to ei-
ther KN99a or KN99using a one-way ANOVA and Dunnet’s posthoc test
with the KN99a strain as the control. The chitin and chitosan values for all
three deletion strains were highly significantly different (P 0.001) from the
value for the KN99a strain.
Donlin et al.















pared to wild-type KN99a (Fig. 4A and C), and measurement of
the capsule diameters showed significantly reduced capsule diam-
eters for bck1, mkk2, and mpk1 strains compared to the wild-
type KN99a strain (Fig. 4B and C and Table 3). The addition of
10 mM cAMP to the medium increased the size of the capsule in all
three deletion strains to wild-type levels while having essentially
no effect on the KN99a strain (Fig. 4B and C and Table 3). These
data point to an important, and previously unknown, role for the
CWI kinases in regulation of cAMP levels. It suggests that produc-
tion of cAMP is dependent on a functioning CWI pathway, as
disruption of the pathway leads to decreased cAMP levels and
causes impairment of capsule induction in LIM.
Analysis of shed capsule in the CWI kinase deletion strains.
The defect in the increase of capsular polysaccharide in the mutant
strains under capsule-inducing conditions suggests that the dis-
ruption of the CWI pathway affects the biosynthesis of the cap-
sule, secretion of the capsule material, or attachment of the se-
creted capsule to the fungal cell wall. To differentiate between
these possible explanations, we collected the shed capsular mate-
rial from the wild-type and mutant strains. Secreted capsular ma-
terial corresponding to an equal number of yeast cells was resolved
on an agarose gel, transferred to a nylon membrane, and probed to
determine the amount and relative size of the capsular material
with an antiglucuronoxylomannan (anti-GXM) antibody (mono-
clonal antibody 3C2). We found that the amounts of capsule shed
by the bck1, mkk2, and mpk1 strains were nearly equal the
amount shed by wild-type cells; however, they exhibited slight
differences in the migration pattern on an agarose gel, suggesting
potential differences in the physical-chemical properties of the
shed capsule material (Fig. 5). Overall, these data suggest that the
observed capsule defects in these strains are more likely due to a
defect in attachment, not in synthesis or secretion.
DISCUSSION
Eukaryotic cellular signaling cascades receive inputs from several
proteins simultaneously and then balance the signals to generate
an appropriate response. One of the kinases in the CWI pathway,
PKC1, plays a central role in the response to various cell wall-
perturbing agents and production of virulence factors, capsule,
and melanin (15, 16). However, the CWI pathway can be induced
by some stresses, such as heat shock, in aPKC1-independent man-
ner (20). To explore possible alternative pathway connections or
cross talk, we determined the global transcription response to the
loss of three other CWI kinases, BCK1, MKK2, and MPK1. We
found that over 1,000 genes were differentially expressed in one or
more of the deletion strains (see Table S2 in the supplemental
material), including 29 cell wall- or capsule-related genes (Ta-
ble 2) and 115 genes with concordant differential expression in all
three strains (Table S3). These data are consistent with a signifi-
cant adaptive response of the cell to the loss of the CWI kinases.
We hypothesized that disruption of three core kinases in the
cell wall integrity pathway affect signaling in other pathways that
impact cell wall and capsule homeostasis and looked for overlap
between the 115 genes showing differential expression in all three
kinase deletion strains (see Table S3 in the supplemental material)
with genes dependent on other stress response-related genes as
well as those that regulate capsule and cell wall homeostasis. We
found a substantial overlap with genes dependent on stress-
responsive HOG1 (29) and SSK1 (34). We also found30 genes
that overlapped with genes dependent on RIM101 (31) and NRG1
(32), which suggested a connection to the cAMP/PKA pathway.
We found a significant reduction in the cellular cAMP levels in all
three of the CWI kinase deletion strains compared to wild-type
cells (Fig. 3A). The addition of exogenous cAMP reduced the sen-
sitivity to some, but not all, cell wall-perturbing agents (Fig. 3B),
suggesting multiple inputs for maintaining cell wall homeostasis
that are dependent on both the cAMP/PKA and CWI pathways.
We observed a loss of surface capsule with deletion of the CWI
kinases and restoration of the surface capsule in those strains with
addition of exogenous cAMP (Fig. 4). This is the first experimental
evidence of a direct connection between the CWI pathway and
FIG 3 The downstream kinase deletion strains produce less cAMP than KN99a cells. (A) The cAMP levels were measured in the different deletion strains. Values
that are statistically significantly different from the value for KN99a strain as determined by a one-way ANOVA with Dunnet’s posthoc test are indicated by an
asterisk. Error bars represent the standard deviations. (B) Phenotypes of bck1,mkk2, andmpk1 deletion strains grown on YPD, YPD plus 0.01% SDS, or YPD
plus 0.01% SDS plus 10 mM cAMP at 3 and 5 days.
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capsule regulation inC. neoformans. The reduced capsule does not
appear to be due to a defect in synthesis or secretion but is more
likely due to a defect in attachment to the cell wall, as we did not
observe a significant difference in the amount of shed capsule
between the wild-type and kinase deletion strains (Fig. 5). The
nature of this defect is not clear, but it is known that -glucan and
chitin oligomers or chitin-like structures are required for capsule
attachment (26, 27, 38). The CWI kinase deletion strains have
reduced chitin/chitosan ratio compared to wild-type cells (Fig. 2),
and a similarly reduced chitin/chitosan ratio was also observed in
chs4 and chs5 strains (25). Expression of both CHS4 and CHS5
was downregulated in all three kinase deletion strains (Table 2);
however, neither the chs4 nor chs5 strain had a measurable
capsule defect when grown in LIM (data not shown). A third chi-
tin synthase gene, CHS1, was upregulated in all three deletion
strains (Table 2), but deletion of CHS1 has no discernible cell
FIG 4 C. neoformans BCK1, MKK2, and MPK1 are required for capsule production. (A and B) Cells were incubated under capsule-inducing conditions for
4 days without cAMP (A) or with 10 mM cAMP (B). Capsule size was assessed by staining with India ink and visualizing the zone of exclusion at a magnification
of60. The capsule diameters of the bck1, mkk2, and mpk1 strains were reduced compared to that of the KN99a strain, and capsule size was restored when
grown with exogenous cAMP. (C) Comparison of capsule diameters between strain KN99a and bck1, mkk2 and mpk1 strains grown in low-iron medium
(LIM) with and without the addition of 10 mM cAMP. Measurements were taken for a minimum of 100 cells for each strain. Asterisks represent statistically
significant differences as determined by a one-way ANOVA with Dunnet’s posthoc test. Error bars represent the 95% confidence intervals.
Donlin et al.















wall-related phenotype (25) or capsule-related phenotype in LIM
(data not shown).
The RIM101 transcription factor has been shown to play a
significant role in the regulation of cell wall morphogenesis (31).
Despite the overlap of genes dependent on all three CWI kinases
with those dependent on RIM101, the rim101 strain has signifi-
cantly different phenotypic characteristics compared to the CWI
kinase deletion strains. The rim101 strain is sensitive to LiCl and
NaCl but insensitive to SDS, calcofluor white, or Congo red. More
interestingly, the rim101 strain has an increased chitin/chitosan
ratio, and two chitin synthase genes,CHS4 andCHS5, are upregu-
lated in the rim101 strain but downregulated in the CWI kinase
deletion strains. This raises the possibility that RIM101 and the
CWI kinases may play antagonistic roles in the regulation of cell
wall homeostasis.
Only three genes with a likely role in transcription regulation
were differentially expressed in all three CWI deletion strains; the
three genes were CNAG_01103, CNAG_05290, and
CNAG_07775 (see Table S3 in the supplemental material). Of the
three genes, only one, CNAG_05290 which encodes SPt3, a sub-
unit of the SAGA transcriptional regulatory complex seems likely
to have a role in cell wall or capsule regulation (32, 39). The
CNAG_05290 transcript for the putative transcription factor,
SPt3, is upregulated in an ada2 strain at 37°C with CO2 com-
pared to the wild type (32), but no further characterization of this
putative transcription factor has been published.
The regulation of capsule production in C. neoformans is very
complex. Capsule synthesis is responsive to iron and CO2 levels
via the cAMP/PKA signaling pathway (reviewed in reference 13),
and the downstream changes in capsule biosynthetic and traffick-
ing gene expression are controlled by at least five different tran-
scription factors, which are also responsive to a number of other
proteins (30, 32, 35, 40–42). Therefore, the hypothesis that the
CWI pathway might have a role in the regulation of capsule pro-
duction is plausible. One possible mechanism of capsule regula-
tion is that the CWI kinases and some subset of chitin synthases
interact to regulate the synthesis of the chitin oligomers that are
necessary for capsule attachment (26, 27). However, experimen-
tally discerning the mechanism of that regulation is beyond the
scope of this study.
In previous studies, deletions of C. neoformans genes with ho-
mology to regulators of the Saccharomyces cerevisiae CWI path-
way,ROM2,LRG1, and SIT4 (reviewed in reference 43) resulted in
moderate to severe cell wall-related phenotypes and increased
sensitivity to cell wall stressors (17). However, we saw no differ-
ential expression of these genes in any of the CWI kinase deletion
strains, nor did we observe differential expression of the regulators
of the HOG pathway, SKN7, SSK1, andTCO1 orTCO2 (33, 34) in
the kinase deletion strains. However, we did observe considerable
overlap between genes differentially expressed in the CWI kinase
deletion strains with genes that are differentially expressed in re-
sponse to the deletion of the stress-responsive genesHOG1, SSK1,
and SKN7 (29, 33, 34). The lack of differences in expression of
genes previously identified as critical for stress response may re-
flect the fact that regulation of their activity occurs primarily via
protein modifications, not by transcriptional changes. We also
conducted our expression analysis of the CWI kinase deletion
strains under nutrient-rich conditions in the absence of exoge-
nous stress. It is possible that if the CWI kinase deletion strains
were exposed to an external stress, we would observe transcrip-
tional changes in some of these other pathway regulators.
In summary, we have demonstrated a direct connection be-
tween the CWI and cAMP/PKA pathways in the regulation of
intracellular cAMP levels. These data support a role for the CWI
pathway in the regulation of surface capsule. The mechanisms and
transcription factors, which mediate the cAMP and capsule re-
sponse to the CWI pathway, remain to be elucidated.









LIM cAMPa P valued
KN99a 2.05 0.61 2.83 0.79 1.00 6.01 1.10 6.16 1.77 0.45
bck1 1.19 0.31 0.001 2.28 0.39 1.00 4.92 0.61 5.58 0.87 0.001
mkk2 1.24 0.24 0.001 1.83 0.51 0.78 4.56 0.72 5.22 0.74 0.001
mpk1 1.18 0.31 0.001 1.48 0.53 1.00 4.36 0.69 5.39 1.2 0.001
a Capsule and cell diameters of cells grown in LIM alone or in LIM plus cAMP are reported as averages standard deviations of at least 100 measurements.
b P value comparing the capsule diameters of deletion strains to that of the WT strain (KN99a) in low-iron medium (LIM) only.
c P value comparing the capsule diameters between deletion strains and WT in LIM plus cAMP.
d P value comparing the cell diameters for each strain with and without cAMP in the medium.
FIG 5 The levels of capsule shed by the bck1, mkk2, and mpk1 strains
were similar to the level shed by the wild-type KN99a strain. The wild-type,
bck1, mkk2, mpk1,and cap59 strains were grown in YPD medium for
5 days, and the number of cells was determined by absorption at 650 nm. The
supernatants were collected, and the cell counts were normalized before load-
ing. The gel was transferred to a blot and probed with the 3C2 anti-GXM
monoclonal antibody.
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Strains and media. Wild-type (WT) C. neoformans var. grubii strain
KN99 (serotype A, MATa) was used in this study (see Table S1 in the
supplemental material). Strains containing deletions inBCK1 orMKK2 in
the KN99 MATa (KN99a) background were generated by overlap PCR
(44) using the primers listed in Table S1. A strain deleted for MPK1 in the
KN99 MATa background was generated by amplification of the mpk1
cassette (pNAT-STM150) from strain KK3, containingmpk1 in the H99
MAT background (generously provided by Joseph Heitman, Duke Uni-
versity) (45). Each fragment was biolistically transformed into strain
KN99a (46), and isolates were selected and verified by PCR screening as
described previously (17) utilizing the primers listed in Table S1. South-
ern blotting was performed, using the selectable marker as a probe to rule
out ectopic integrations.
RNA preparation and sequencing. The KN99a, bck1, mkk2, and
mpk1 cells were grown for 3 days on plates containing yeast extract-
peptone-dextrose (YPD) medium supplemented with 1 M D-sorbitol. A
50-ml flask of YPD medium supplemented with 1 M sorbitol was inocu-
lated and grown overnight at 30°C with shaking (300 rpm). Cells were
diluted to an optical density at 650 nm (OD650) of 0.004 and grown over-
night to an OD650 of 0.75 to 1.0. A strain with a deletion in the PKC1 gene,
which required sorbitol to grow, was originally part of this study, but it
was later determined to have an aneuploid chromosome. It was excluded
from further analyses (data not shown). RNA was prepared from three
biological replicates using the Qiagen RNeasy plant minikit (Qiagen, Va-
lencia, CA) with minor modifications (details of methods available upon
request). RNA quality was assessed on a formaldehyde agarose gel, and the
ratio of 25S/18S rRNA was quantified using ImageQuant software (GE
Healthcare Biosciences, Pittsburgh, PA). Total RNA (10 g) from each
sample was used as starting material to prepare sequencing libraries with
the Illumina mRNA sequencing sample preparation kit (Illumina, San
Diego, CA) following the manufacturer’s instructions. Samples were bar-
coded and sequenced on a single lane of an Illumina HiSeq sequencing
system to generate nondirectional, single-ended 50-bp reads. The library
preparation and RNA sequencing were performed by the Genome Access
Technology Center at Washington University (http://gtac.wustl.edu).
The bar code sequences were trimmed to 42 bp, and quality-filtered reads
were mapped to the H99 reference genome sequence prepared by the
Broad Institute (http://www.broadinstitute.org/annotation/genome
/cryptococcus_neoformans/MultiHome.html) using Bow tie 2.1.0 as im-
plemented in the TopHat-Cufflinks suite (21, 47).
Differential gene expression. The C. neoformans H99 transcript file
prepared by the Broad Institute was used as the reference. Transcript files
for each biological replicate were generated from each alignment file using
Cufflinks, merged into a single transcript file using Cuffmerge, and differ-
entially expressed transcripts were identified using Cuffdiff (21). Genes
were considered differentially expressed if P values were 0.05 after
Benjamini-Hochberg correction for multiple testing.
Capsule measurements. Strains were grown in low-iron medium
[LIM plus ethylenediamine-N,N=-bis(2-hydroxyphenylacetic acid) (ED-
DHA)] (37) with and without exogenous 10 mM cAMP for 4 days at 30°C.
All mutant strains were compared to the wild-type KN99a strain. Capsule-
induced strains were suspended in a 1:4 India ink-H2O solution and pho-
tographed on an Olympus BX61 microscope at a magnification of 60.
Cell diameters (one including the capsule and one excluding it) were
measured for a minimum of 100 cells per strain using SlideBook, version
5.0. Capsule length was calculated as the difference between the radii
obtained from the diameters. All values were averaged, and comparisons
were considered significant if the P value was 0.05 using a one-way
analysis of variance (ANOVA) with a Dunnet’s posthoc test (one-tailed
comparison; control).
Chitin and chitosan assays. The cellular chitin and chitosan levels
were determined as previously described (22). Samples were divided into
two aliquots. One aliquot was treated with acetic anhydride to measure
chitin plus chitosan. The other aliquot was left untreated to measure total
chitin. Chitosan was estimated from the difference between the two mea-
surements.
Measurement of cAMP. Overnight cultures of the WT and the dele-
tion strains were diluted in 50 ml YPD medium to an OD650 of 0.05 and
grown for 20 h at 30°C with shaking (300 rpm). Cells were harvested,
washed, and resuspended in MES-EDTA buffer (10 mM morpho-
lineethanesulfonic acid [MES], 0.1 mM EDTA, pH 6.0). Cells were
counted using a hemocytometer, centrifuged, and resuspended at a con-
centration of 5 108 cells/ml. Cells (0.5 ml) were lysed by bead beating in
2.5% trichloroacetic acid at 4°C with 0.5-mm glass beads for 1 min, fol-
lowed by a 2-min rest, for a total of 4 cycles. Crude lysates were centrifuged
at 20,800  g for 15 min. Lysates were extracted four times with water-
saturated diethyl ether and centrifuged for 20,800  g at 4°C for 2 min
between extractions, frozen in liquid nitrogen, and lyophilized overnight.
The lyophilized samples were suspended in 0.5 ml of 0.1 M HCl, and
cAMP assays were performed according to Sigma cAMP enzyme immu-
noassay kit (catalog no. CA200; Sigma, St. Louis, MO). Assays were per-
formed twice with three technical replicates. cAMP concentrations were
calculated for individual samples, and statistical significance was deter-
mined using a one-way ANOVA with Dunnet’s posthoc test (two-tailed
test) using IBM SPSS Statistics (version 20).
SDS viability assays. Overnight cultures of wild-type strain KN99a
and bck1,mkk2, andmpk1 strains in YPD medium were diluted to an
OD650 of 1.0 with phosphate-buffered saline (PBS). Tenfold serial dilu-
tions were plated on YPD medium plus 0.01% SDS and YPD medium plus
0.01% SDS and 10 mM cAMP. The plates were incubated at 30°C for up to
5 days and photographed. The SDS concentration used was based on
levels determined to be deleterious, but not lethal, to the mutant strains.
Immunoblotting of the secreted capsule. Immunoblotting of the
shed capsular material was performed as described previously (48).
Briefly, conditioned medium for each strain corresponding to an equal
number of yeast cells grown in YPD medium was passed through a
0.22-m filter, mixed with DNA loading dye, and separated on a 0.6%
agarose gel using Tris-acetic acid-EDTA buffer (pH 8.0). The gel was
transferred onto a positively charged nylon membrane by capillary trans-
fer and immunoblotted with 1g/ml of antiglucuronoxylomannan (anti-
GXM) 3C2 antibody (generously provided by Thomas Kozel, University
of Nevada) (49).
Microarray data accession number. RNA sequences/microarray data
were deposited in the NCBI GEO database and assigned accession number
GSE57217.
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